{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:02:36Z","timestamp":1782824556326,"version":"3.54.5"},"reference-count":26,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"unspecified","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"French Ministry of Health","award":["PHRCI-18-056"],"award-info":[{"award-number":["PHRCI-18-056"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,2,12]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Patients with haematological malignancies undergoing intensive chemotherapy with or without haematopoietic cell transplantation (HCT) are at high risk of complications that may require intensive care. While some studies advocate for early admission of these patients to the intensive care unit (ICU), it has not been formally demonstrated that admission to the ICU as soon as patients have organ injury may improve their outcomes. To demonstrate the efficacy of implementing the National Early Warning System (NEWS) with immediate ICU admission for patients with NEWS \u22657\u2009to decrease hospital mortality and organ failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>ALHERT is a randomised cluster, controlled trial carried out in 10 French centres. With their informed consent, adult patients undergoing induction therapy for acute lymphoblastic or myeloblastic leukaemia, autologous or allogeneic HCT in one of the participating centres will be included. Five centres will follow local guidelines for ICU admission (control group) while five centres will assess the NEWS at least three times per day with immediate ICU admission for patients with NEWS \u22657 (interventional group). The primary outcome is hospital mortality without organ sustaining therapy. Secondary objectives will be to study the relative weight of each parameter used to calculate the NEWS for predicting the risk of organ failure requiring life-sustaining organ support, to evaluate the feasibility of implementing early warning scores in routine practice by analysing the proportion of patients with NEWS \u22657 effectively admitted to the ICU in the investigational arm, to assess quality of life with EQ-5D-5L (five level European Quality of Life five Dimensions) and assess the cost-effectiveness of this strategy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The protocol has been approved by the Comit\u00e9 de Protection des Personnes Ile de France I (Ethics Review ID-RCB: 2024-A00969-38). It is carried out in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. The findings of this study will be presented in peer-reviewed journals and at scientific conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06409767\">NCT06409767<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-113466","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:35:21Z","timestamp":1773934521000},"page":"e113466","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of an early warning system on the outcome of patients with haematological malignancies receiving high-dose chemotherapy with or without haematopoietic cell transplantation: a protocol of the ALHERT cluster randomised trial"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06409767","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Mathilde","family":"Taillantou-Candau","sequence":"first","affiliation":[{"name":"D\u00e9partement de M\u00e9decine Intensive-R\u00e9animation, CHU d\u2019Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Kouatchet","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine Intensive-R\u00e9animation, CHU d\u2019Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Darsonval","sequence":"additional","affiliation":[{"name":"Pharmacie Hospitali\u00e8re, CHU Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Monmousseau","sequence":"additional","affiliation":[{"name":"Unit\u00e9 Evaluation M\u00e9dico Economique, CHU de Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0851-6140","authenticated-orcid":false,"given":"Elise","family":"Darras","sequence":"additional","affiliation":[{"name":"Maladies du Sang, CHU d\u2019Angers, Angers, France"},{"name":"F\u00e9d\u00e9ration Hospitalo-Universitaire Grand-Ouest Acute Leukemia, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Maladies du Sang, CHU d\u2019Angers, Angers, France"},{"name":"F\u00e9d\u00e9ration Hospitalo-Universitaire Grand-Ouest Acute Leukemia, Angers, France"},{"name":"Universit\u00e9 d'Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes Universit\u00e9, CRCI2NA, F-49000 Angers, Universit\u00e9 d\u2019Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Riou","sequence":"additional","affiliation":[{"name":"D\u00e9partement de statistiques, CHU d\u2019Angers, Angers, France"},{"name":"Univ Angers, Angers, France"},{"name":"CNRS, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8717-0824","authenticated-orcid":false,"given":"Corentin","family":"Orvain","sequence":"additional","affiliation":[{"name":"Maladies du Sang, CHU d\u2019Angers, Angers, France"},{"name":"F\u00e9d\u00e9ration Hospitalo-Universitaire Grand-Ouest Acute Leukemia, Angers, France"},{"name":"Universit\u00e9 d'Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes Universit\u00e9, CRCI2NA, F-49000 Angers, Universit\u00e9 d\u2019Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"2026031908351837000_16.3.e113466.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70208-4"},{"key":"2026031908351837000_16.3.e113466.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70255-9"},{"key":"2026031908351837000_16.3.e113466.3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bmt.2013.141","article-title":"Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT","volume":"49","author":"Benz","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"2026031908351837000_16.3.e113466.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.5867"},{"key":"2026031908351837000_16.3.e113466.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.9073"},{"key":"2026031908351837000_16.3.e113466.6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.031583"},{"key":"2026031908351837000_16.3.e113466.7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamaoncol.2016.4858","article-title":"Association of Risk Factors, Mortality, and Care Costs of Adults With Acute Myeloid Leukemia With Admission to the Intensive Care Unit","volume":"3","author":"Halpern","year":"2017","journal-title":"JAMA Oncol"},{"key":"2026031908351837000_16.3.e113466.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.2365"},{"key":"2026031908351837000_16.3.e113466.9","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-019-0587-7","article-title":"Direct admission to the intensive care unit from the emergency department and mortality in critically ill hematology patients","volume":"9","author":"Peyrony","year":"2019","journal-title":"Ann Intensive Care"},{"key":"2026031908351837000_16.3.e113466.10","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00277-018-3320-y","article-title":"Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence","volume":"97","author":"Orvain","year":"2018","journal-title":"Ann Hematol"},{"key":"2026031908351837000_16.3.e113466.11","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.753446"},{"key":"2026031908351837000_16.3.e113466.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201001-0018OC"},{"key":"2026031908351837000_16.3.e113466.13","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31822b50c2"},{"key":"2026031908351837000_16.3.e113466.14","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/CCM.0000000000000989","article-title":"Effect of Early Intervention on Long-Term Outcomes of Critically Ill Cancer Patients Admitted to ICUs*","volume":"43","author":"Lee","year":"2015","journal-title":"Crit Care Med"},{"key":"2026031908351837000_16.3.e113466.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-012-2594-0"},{"key":"2026031908351837000_16.3.e113466.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1501","article-title":"Early warning scores for detecting deterioration in adult hospital patients: systematic review and critical appraisal of methodology","volume":"369","author":"Gerry","year":"2020","journal-title":"BMJ"},{"key":"2026031908351837000_16.3.e113466.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2014.01.013"},{"key":"2026031908351837000_16.3.e113466.18","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201403-102OC"},{"key":"2026031908351837000_16.3.e113466.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.12.455"},{"key":"2026031908351837000_16.3.e113466.20","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/cid\/ciaa214","article-title":"Predictive Value of 3 Clinical Criteria for Sepsis (Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and National Early Warning Score) With Respect to Short-term Mortality in Allogeneic Hematopoietic Cell Transplant Recipients With Suspected Infections","volume":"72","author":"Lind","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026031908351837000_16.3.e113466.21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/ejh.13952","article-title":"Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy","volume":"110","author":"Frairia","year":"2023","journal-title":"Eur J Haematol"},{"key":"2026031908351837000_16.3.e113466.22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00277-009-0853-0","article-title":"Impact of critical care reconfiguration and track-and-trigger outreach team intervention on outcomes of haematology patients requiring intensive care admission","volume":"89","author":"Bokhari","year":"2010","journal-title":"Ann Hematol"},{"key":"2026031908351837000_16.3.e113466.23","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41591-025-03635-5","article-title":"CONSORT 2025 statement: updated guideline for reporting randomized trials","volume":"31","author":"Hopewell","year":"2025","journal-title":"Nat Med"},{"key":"2026031908351837000_16.3.e113466.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2018.03.109"},{"key":"2026031908351837000_16.3.e113466.25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00277-023-05205-6","article-title":"Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission - a multi-center study","volume":"102","author":"Desprez","year":"2023","journal-title":"Ann Hematol"},{"key":"2026031908351837000_16.3.e113466.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081477","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"389","author":"Chan","year":"2025","journal-title":"BMJ"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-113466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:35:23Z","timestamp":1773934523000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-113466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,19]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjopen-2025-113466"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-113466","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}